MedTrace Logo

A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules

NCT06074133 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2026-05-04

No results posted yet for this study

Summary

This is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.

Conditions

  • Pulmonary Nodule

Interventions

PROCEDURE

Blood collection

Undergo blood draw

PROCEDURE

Chest Computed Tomography

Undergo standard of care chest Computed Tomography

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Eric Grogan, MD · Vanderbilt University/Ingram Cancer Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-07
Primary Completion
2027-03-31
Completion
2029-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06074133 on ClinicalTrials.gov